Cme (CME) Capital Expenditures (2010 - 2026)

Cme (CME) has reported Capital Expenditures for 17 consecutive years, with $23.6 million the latest figure, recorded in Q2 2026.

• Quarterly Capital Expenditures rose 28.26% year-over-year to $23.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $96.3 million (up 8.69% YoY) and the FY2025 annual result came in at $83.5 million, down 11.17% from the prior year.
• Capital Expenditures grew to $23.6 million in Q2 2026 per CME's latest filing, from $21.8 million in the prior quarter.
• Over the last five years, Capital Expenditures for CME reached as high as $32.5 million in Q4 2025 and fell as low as $14.2 million in Q1 2025.
• A 5-year average of $21.6 million and a median of $20.6 million in 2023 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2022 — Capital Expenditures plunged 54.91% — and 2026, when it jumped 53.52%.
• Year by year, Capital Expenditures stood at $24.4 million in 2022, then fell by 14.75% to $20.8 million in 2023, then gained by 25.96% to $26.2 million in 2024, then increased by 24.05% to $32.5 million in 2025, then retreated by 27.38% to $23.6 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $23.6 million, $21.8 million, and $32.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.